Equity Investment Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $178M | Sell |
3,221,035
-889,544
| -22% | -$48.2M | 3.48% | 2 |
|
|
2025
Q4 | $202M | Sell |
4,110,579
-158,996
| -4% | -$7.42M | 4.07% | 1 |
|
|
2025
Q3 | $184M | Buy |
4,269,575
+76,794
| +2% | +$3M | 3.86% | 2 |
|
|
2025
Q2 | $161M | Buy |
4,192,781
+18,592
| +0.4% | +$710K | 3.53% | 2 |
|
|
2025
Q1 | $162M | Buy |
4,174,189
+211,608
| +5% | +$7.75M | 3.62% | 4 |
|
|
2024
Q4 | $134M | Buy |
3,962,581
+466,327
| +13% | +$16.8M | 3.14% | 6 |
|
|
2024
Q3 | $143M | Buy |
3,496,254
+63,052
| +2% | +$2.58M | 3.33% | 7 |
|
|
2024
Q2 | $132M | Buy |
3,433,202
+34,631
| +1% | +$1.46M | 3.38% | 5 |
|
|
2024
Q1 | $146M | Buy |
3,398,571
+155,312
| +5% | +$6.4M | 3.64% | 6 |
|
|
2023
Q4 | $120M | Sell |
3,243,259
-34,103
| -1% | -$1.22M | 3.38% | 5 |
|
|
2023
Q3 | $119M | Buy |
3,277,362
+90,579
| +3% | +$3.21M | 3.7% | 3 |
|
|
2023
Q2 | $114M | Sell |
3,186,783
-113,448
| -3% | -$4.07M | 3.51% | 3 |
|
|
2023
Q1 | $117M | Buy |
3,300,231
+422,438
| +15% | +$14.8M | 3.85% | 3 |
|
|
2022
Q4 | $101M | Buy |
2,877,793
+261,161
| +10% | +$8.7M | 3.4% | 7 |
|
|
2022
Q3 | $77M | Buy |
2,616,632
+123,202
| +5% | +$4.67M | 2.95% | 11 |
|
|
2022
Q2 | $136M | Buy |
2,493,430
+52,981
| +2% | +$2.92M | 5.02% | 1 |
|
|
2022
Q1 | $133M | Buy |
2,440,449
+94,787
| +4% | +$5.15M | 4.54% | 2 |
|
|
2021
Q4 | $129M | Buy |
2,345,662
+6,201
| +0.3% | +$323K | 4.68% | 1 |
|
|
2021
Q3 | $112M | Sell |
2,339,461
-28,580
| -1% | -$1.44M | 4.28% | 1 |
|
|
2021
Q2 | $118M | Buy |
2,368,041
+55,007
| +2% | +$2.64M | 4.44% | 1 |
|
|
2021
Q1 | $103M | Buy |
2,313,034
+456,103
| +25% | +$20.7M | 4.1% | 2 |
|
|
2020
Q4 | $85.4M | Buy |
1,856,931
+390,003
| +27% | +$17.9M | 3.98% | 2 |
|
|
2020
Q3 | $69M | Sell |
1,466,928
-63,928
| -4% | -$3.2M | 3.51% | 4 |
|
|
2020
Q2 | $78.1M | Sell |
1,530,856
-131,082
| -8% | -$6.73M | 3.88% | 3 |
|
|
2020
Q1 | $78.7M | Sell |
1,661,938
-270,095
| -14% | -$14.4M | 4.06% | 4 |
|
|
2019
Q4 | $113M | Sell |
1,932,033
-70,374
| -4% | -$3.91M | 3.9% | 2 |
|
|
2019
Q3 | $107M | Sell |
2,002,407
-136,604
| -6% | -$7.03M | 3.81% | 3 |
|
|
2019
Q2 | $107M | Sell |
2,139,011
-82,422
| -4% | -$4.14M | 3.74% | 4 |
|
|
2019
Q1 | $116M | Buy |
2,221,433
+84,035
| +4% | +$4.2M | 3.92% | 2 |
|
|
2018
Q4 | $102M | Sell |
2,137,398
-228,744
| -10% | -$11.3M | 3.68% | 3 |
|
|
2018
Q3 | $119M | Sell |
2,366,142
-108,500
| -4% | -$5.51M | 3.83% | 3 |
|
|
2018
Q2 | $125M | Sell |
2,474,642
-76,354
| -3% | -$3.85M | 4.05% | 4 |
|
|
2018
Q1 | $125M | Buy |
2,550,996
+878,900
| +53% | +$40.9M | 4.13% | 2 |
|
|
2017
Q4 | $74.1M | Sell |
1,672,096
-321,545
| -16% | -$14.9M | 2.47% | 24 |
|
|
2017
Q3 | $101M | Sell |
1,993,641
-2,093
| -0.1% | -$106K | 3.49% | 8 |
|
|
2017
Q2 | $108M | Sell |
1,995,734
-238,264
| -11% | -$12.7M | 3.68% | 8 |
|
|
2017
Q1 | $118M | Buy |
2,233,998
+370,423
| +20% | +$18.8M | 3.83% | 5 |
|
|
2016
Q4 | $89.7M | Buy |
+1,863,575
| New | +$92.1M | 2.89% | 18 |
|
Other funds holding GSK
JEST
